4.0 Review

Opening the DOR on antidepressant effects

期刊

MOLECULAR INTERVENTIONS
卷 6, 期 3, 页码 162-169

出版社

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mi.6.3.7

关键词

-

资金

  1. NIDA NIH HHS [DA00254, T32 DA07267] Funding Source: Medline
  2. NIGMS NIH HHS [T32 GM07767] Funding Source: Medline
  3. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE ON DRUG ABUSE [P01DA000254, P50DA000254, T32DA007267] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Activation of the delta-opioid receptor (DOR) system produces an interesting behavioral profile distinct from that of other opioids. Unlike mu- and kappa-opioid agonists, delta-opioid agonists alone have limited pain-relieving qualities as measured in morphine-sensitive antinociceptive assays. Recent evidence, however, suggests that the DOR system may play a role in regulating mood and emotional states. For example, DOR activation stimulates robust antidepressant-like effects in preclinical assays, suggesting that these compounds may have therapeutic potential for treating human depression. This review discusses the role of the DORs in depression and the antidepressant-like effects of delta-opioid agonists as well as their limitations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据